Van Willis

Van Willis has a strong background in scientific communications and healthcare strategy. Van is currently working at Inari Medical as a Senior Principal, Scientific Communications, where they are responsible for tracking and communicating developments in the venous thromboembolism field. Prior to that, Van worked at IBM as a Senior Biomedical Writer and later as a Watson Health Life Sciences Solutions Executive. Van also has experience in pricing and market access strategy, having worked as a Senior Consultant at ICON plc. Additionally, Van has interned at the Colorado Institute for Drug, Device and Diagnostic Development, where they evaluated prospective technologies and provided IP analyses. Van also pursued a PhD at UC Denver Anchutz Medical Campus, conducting research on the role of PADs in autoimmune diseases. Furthermore, Van served as President of Alternatives in Science, a student organization focused on providing career advice and education in the science industry.

Van Willis completed a Bachelor of Science degree in Microbiology from Brigham Young University in 2007. From 2007 to 2012, they attended the University of Colorado Denver School of Medicine where they earned their PhD in Molecular Biology. Van also obtained additional certifications, including a BioMARC Preclinical Aspects of Product Translation Short Course, a BioMARC Product Translation Pathway and Related FDA Regulations Short Course, a Clinical-translational science PhD certificate training, and a University of Denver GMP/GLP Certificate. Further information on the institutions and years of obtaining the certifications is not provided.